These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34980538)

  • 21. Upper limb function in Duchenne muscular dystrophy: 24 month longitudinal data.
    Pane M; Coratti G; Brogna C; Mazzone ES; Mayhew A; Fanelli L; Messina S; D'Amico A; Catteruccia M; Scutifero M; Frosini S; Lanzillotta V; Colia G; Cavallaro F; Rolle E; De Sanctis R; Forcina N; Petillo R; Barp A; Gardani A; Pini A; Monaco G; D'Angelo MG; Zanin R; Vita GL; Bruno C; Mongini T; Ricci F; Pegoraro E; Bello L; Berardinelli A; Battini R; Sansone V; Albamonte E; Baranello G; Bertini E; Politano L; Sormani MP; Mercuri E
    PLoS One; 2018; 13(6):e0199223. PubMed ID: 29924848
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Instruments to assess upper-limb function in children and adolescents with neuromuscular diseases: a systematic review.
    Davoli GBQ; Cardoso J; Silva GC; Moreira RFC; Mattiello-Sverzut AC
    Dev Med Child Neurol; 2021 Sep; 63(9):1030-1037. PubMed ID: 33834485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Old measures and new scores in spinal muscular atrophy patients.
    Mazzone E; Montes J; Main M; Mayhew A; Ramsey D; Glanzman AM; Dunaway S; Salazar R; Pasternak A; Quigley J; Pane M; Pera MC; Scoto M; Messina S; Sframeli M; D'amico A; Van Den Hauwe M; Sivo S; Goemans N; Darras BT; Kaufmann P; Bertini E; De Vivo DC; Muntoni F; Finkel R; Mercuri E
    Muscle Nerve; 2015 Sep; 52(3):435-7. PubMed ID: 26111847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy.
    Montes J; Glanzman AM; Mazzone ES; Martens WB; Dunaway S; Pasternak A; Riley SO; Quigley J; Pandya S; De Vivo DC; Kaufmann P; Chiriboga CA; Finkel RS; Tennekoon GI; Darras BT; Pane M; Mercuri E; Mcdermott MP;
    Muscle Nerve; 2015 Dec; 52(6):942-7. PubMed ID: 25846132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials.
    Mercuri E; Finkel R; Montes J; Mazzone ES; Sormani MP; Main M; Ramsey D; Mayhew A; Glanzman AM; Dunaway S; Salazar R; Pasternak A; Quigley J; Pane M; Pera MC; Scoto M; Messina S; Sframeli M; Vita GL; D'Amico A; van den Hauwe M; Sivo S; Goemans N; Kaufmann P; Darras BT; Bertini E; Muntoni F; De Vivo DC
    Neuromuscul Disord; 2016 Feb; 26(2):126-31. PubMed ID: 26776503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.
    Wadman RI; Wijngaarde CA; Stam M; Bartels B; Otto LAM; Lemmink HH; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    Eur J Neurol; 2018 Mar; 25(3):512-518. PubMed ID: 29194869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen.
    Sansone VA; Coratti G; Pera MC; Pane M; Messina S; Salmin F; Albamonte E; De Sanctis R; Sframeli M; Di Bella V; Morando S; d'Amico A; Frongia AL; Antonaci L; Pirola A; Pedemonte M; Bertini E; Bruno C; Mercuri E;
    Eur J Neurol; 2021 Feb; 28(2):602-608. PubMed ID: 33012052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Change in muscle strength over time in spinal muscular atrophy types II and III. A long-term follow-up study.
    Werlauff U; Vissing J; Steffensen BF
    Neuromuscul Disord; 2012 Dec; 22(12):1069-74. PubMed ID: 23127961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nusinersen efficacy data for 24-month in type 2 and 3 spinal muscular atrophy.
    Pane M; Coratti G; Pera MC; Sansone VA; Messina S; d'Amico A; Bruno C; Salmin F; Albamonte E; De Sanctis R; Sframeli M; Di Bella V; Morando S; Palermo C; Frongia AL; Antonaci L; Capasso A; Catteruccia M; Longo A; Ricci M; Cutrona C; Pirola A; Bravetti C; Pedemonte M; Brolatti N; Bertini E; Mercuri E;
    Ann Clin Transl Neurol; 2022 Mar; 9(3):404-409. PubMed ID: 35166467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients.
    Zerres K; Rudnik-Schöneborn S; Forrest E; Lusakowska A; Borkowska J; Hausmanowa-Petrusewicz I
    J Neurol Sci; 1997 Feb; 146(1):67-72. PubMed ID: 9077498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal Fluid and Clinical Profiles in Adult Type 2-3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience.
    Milella G; Introna A; D'Errico E; Fraddosio A; Scaglione G; Morea A; Ucci M; Ruggieri M; Mastrapasqua M; Megna M; Puntillo F; Simone IL
    Clin Drug Investig; 2021 Sep; 41(9):775-784. PubMed ID: 34389971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative description of upper extremity function and activity of people with spinal muscular atrophy.
    Janssen MMHP; Peeters LHC; de Groot IJM
    J Neuroeng Rehabil; 2020 Sep; 17(1):126. PubMed ID: 32917233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy.
    Febrer A; Rodriguez N; Alias L; Tizzano E
    J Rehabil Med; 2010 Mar; 42(3):228-31. PubMed ID: 20411217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study.
    Chabanon A; Seferian AM; Daron A; Péréon Y; Cances C; Vuillerot C; De Waele L; Cuisset JM; Laugel V; Schara U; Gidaro T; Gilabert S; Hogrel JY; Baudin PY; Carlier P; Fournier E; Lowes LP; Hellbach N; Seabrook T; Toledano E; Annoussamy M; Servais L;
    PLoS One; 2018; 13(7):e0201004. PubMed ID: 30048507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nusinersen in adults with 5q spinal muscular atrophy: a non-interventional, multicentre, observational cohort study.
    Hagenacker T; Wurster CD; Günther R; Schreiber-Katz O; Osmanovic A; Petri S; Weiler M; Ziegler A; Kuttler J; Koch JC; Schneider I; Wunderlich G; Schloss N; Lehmann HC; Cordts I; Deschauer M; Lingor P; Kamm C; Stolte B; Pietruck L; Totzeck A; Kizina K; Mönninghoff C; von Velsen O; Ose C; Reichmann H; Forsting M; Pechmann A; Kirschner J; Ludolph AC; Hermann A; Kleinschnitz C
    Lancet Neurol; 2020 Apr; 19(4):317-325. PubMed ID: 32199097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory Trajectories in Type 2 and 3 Spinal Muscular Atrophy in the iSMAC Cohort Study.
    Trucco F; Ridout D; Scoto M; Coratti G; Main ML; Muni Lofra R; Mayhew AG; Montes J; Pane M; Sansone V; Albamonte E; D'Amico A; Bertini E; Messina S; Bruno C; Parasuraman D; Childs AM; Gowda V; Willis T; Ong M; Marini-Bettolo C; De Vivo DC; Darras BT; Day J; Kichula EA; Mayer OH; Navas Nazario AA; Finkel RS; Mercuri E; Muntoni F;
    Neurology; 2021 Jan; 96(4):e587-e599. PubMed ID: 33067401
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responsiveness of the motor function measure in patients with spinal muscular atrophy.
    Vuillerot C; Payan C; Iwaz J; Ecochard R; Bérard C;
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1555-61. PubMed ID: 23380348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spinal muscular atrophy: survival pattern and functional status.
    Chung BH; Wong VC; Ip P
    Pediatrics; 2004 Nov; 114(5):e548-53. PubMed ID: 15492357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year.
    Kaufmann P; McDermott MP; Darras BT; Finkel R; Kang P; Oskoui M; Constantinescu A; Sproule DM; Foley AR; Yang M; Tawil R; Chung W; Martens B; Montes J; O'Hagen J; Dunaway S; Flickinger JM; Quigley J; Riley S; Glanzman AM; Benton M; Ryan PA; Irvine C; Annis CL; Butler H; Caracciolo J; Montgomery M; Marra J; Koo B; De Vivo DC; ;
    Arch Neurol; 2011 Jun; 68(6):779-86. PubMed ID: 21320981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimal clinically important differences in functional motor scores in adults with spinal muscular atrophy.
    Stolte B; Bois JM; Bolz S; Kizina K; Totzeck A; Schlag M; Kleinschnitz C; Hagenacker T
    Eur J Neurol; 2020 Dec; 27(12):2586-2594. PubMed ID: 32781490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.